Mutations and thrombosis in essential thrombocythemia | Blood Cancer Journal
Advances in germline predisposition to acute leukaemias and myeloid neoplasms | Nature Reviews Cancer
Mutations and thrombosis in essential thrombocythemia | Blood Cancer Journal
Essential thrombocythemia | Orphanet Journal of Rare Diseases | Full Text
The clinical features of four JAK2 V617F+ essential thrombocythemia and... | Download Scientific Diagram
Essential thrombocythemia and primary myelofibrosis | Basicmedical Key
Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic era | Leukemia
Treatment algorithm for essential thrombocythemia | Download Scientific Diagram
Classification and regression tree based on all 213 patients with... | Download Scientific Diagram
Genetic loss of SH2B3 in acute lymphoblastic leukemia - ScienceDirect
Limitations of the Human Reference Genome for Personalized Genomics | PLOS ONE
Genomic characterization of spleens in patients with myelofibrosis
SNPs Array Karyotyping Reveals a Novel Recurrent 20p13 Amplification in Primary Myelofibrosis | PLOS ONE
Current treatment algorithm in essential thrombocythemia Second-line... | Download Scientific Diagram
Austrian recommendations for the management of essential thrombocythemia | SpringerLink
The Cytogenetics of Hematologic Neoplasms | Basicmedical Key
Essential thrombocythemia treatment algorithm 2018 | Blood Cancer Journal
MPL-mutated essential thrombocythemia: a morphologic reappraisal | Blood Cancer Journal
Cureus | Familial Essential Thrombocythemia With Novel MPL L502G and G208K Mutations | Article
Frontiers | Primary Immunodeficiency and Cancer Predisposition Revisited: Embedding Two Closely Related Concepts Into an Integrative Conceptual Framework
Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations | Haematologica
JAK2 Reflex for Essential Thrombocythemia
SNPs Array Karyotyping Reveals a Novel Recurrent 20p13 Amplification in Primary Myelofibrosis | PLOS ONE
Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk - ScienceDirect
Frontiers | Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study
